{
 "awd_id": "9222464",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "New Medically Useful, Ionically Modified Lactide/Glycolide  Polymers",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Kesh S. Narayanan",
 "awd_eff_date": "1993-07-15",
 "awd_exp_date": "1996-06-30",
 "tot_intn_awd_amt": 289284.0,
 "awd_amount": 289284.0,
 "awd_min_amd_letter_date": "1993-07-13",
 "awd_max_amd_letter_date": "1999-01-11",
 "awd_abstract_narration": "This Phase II SBIR grant will allow BIOTEK to do research on                    low molecular weight metal polymer salts that can be used as                    biodegradable implants or injections.  Many medical                             therapies can benefit from drug delivery using biodegradable                    implants or injections.  The FDA-approved polymers used for                     this purpose are polyesters of lactic and glycolic acids                        (PLGs) which are limited to rather slow degradation in the                      body.  PLGs with a molecular weight low enough to degrade                       quickly are syrups or sticky solids. BIOTEK is seeking to                       improve PLGs by using low molecular weight metal polymers                       salts that have both good physical properties and shortened                     degradation times.  Phase I confirmed that such salts can be                    strong and non-tacky.  These new materials open the door to                     many new medical products; the company's commercial interest                    lie chiefly in producing PLG salts for the drug delivery                        field.  In Phase II BIOTEK will investigate alternative                         methods of production; verify reproducibility and purity;                       prepare injectable and implantable drug delivery systems;                       and assess delivery, irritation, and resorption                                 characteristics.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Larry",
   "pi_last_name": "Nichols",
   "pi_mid_init": "D",
   "pi_sufx_name": "",
   "pi_full_name": "Larry D Nichols",
   "pi_email_addr": "",
   "nsf_id": "000273570",
   "pi_start_date": "1993-07-15",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "BIOTEK, Inc.",
  "inst_street_address": "21-C Olympia Avenue",
  "inst_street_address_2": "",
  "inst_city_name": "Woburn",
  "inst_state_code": "MA",
  "inst_state_name": "Massachusetts",
  "inst_phone_num": "6179380938",
  "inst_zip_code": "018016307",
  "inst_country_name": "United States",
  "cong_dist_code": "05",
  "st_cong_dist_code": "MA05",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "BIOTEK, Inc.",
  "perf_str_addr": "21-C Olympia Avenue",
  "perf_city_name": "Woburn",
  "perf_st_code": "MA",
  "perf_st_name": "Massachusetts",
  "perf_zip_code": "018016307",
  "perf_ctry_code": "US",
  "perf_cong_dist": "05",
  "perf_st_cong_dist": "MA05",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537300",
   "pgm_ele_name": "SBIR Phase II"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "5345",
   "pgm_ref_txt": "BIOMEDICAL ENGINEERING"
  },
  {
   "pgm_ref_code": "5373",
   "pgm_ref_txt": "SMALL BUSINESS PHASE II"
  },
  {
   "pgm_ref_code": "9108",
   "pgm_ref_txt": "BIOMOLECULAR MATERIALS"
  }
 ],
 "app_fund": [
  {
   "app_code": "0493",
   "app_name": "NSF, EDUCATION & HUMAN RESOURC",
   "app_symb_id": "490106",
   "fund_code": "app-0493",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 1993,
   "fund_oblg_amt": 289284.0
  }
 ],
 "por": null
}